Stocks · US
ICLR
XNAS
Icon Plc
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E38.45x
P/B6.71x
P/S4.42x
EPS$4.38
ROE17.46%
ROA9.74%
Dividend yield0.00%
EV/EBITDA26.40x
Debt/Equity0.18
Free cash flow$489M
Returns and 52-week range
1W-5.08%
1M-1.92%
3M-2.28%
6M+50.89%
1Y-16.61%
YTD-14.30%
52W high$203.91
52W low$66.57
From 52W high-20.71%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Corcept Therapeutics Inc. | $13.2B | 242.09 | 18.69 | +7.12% |
| BridgeBio Pharma, Inc. Common Stock | $12.9B | — | — | -10.53% |
| 트위스트 바이오사이언스 | $13.6B | — | 30.49 | +33.88% |
| 10X 지노믹스 | $12.7B | — | 15.43 | +28.75% |
| Exelixis Inc | $14.6B | 16.94 | 7.91 | -1.15% |
| Baxter International Inc. | $12.5B | — | 2.02 | -5.69% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.